Veeva Systems

VEEV

Market cap $28.5B

VEEV and IQV are benefiting from life sciences digitization trends, but differences in growth, AI adoption and valuation set them apart.

Get a deeper insight into the potential performance of Veeva (VEEV) for the quarter ended April 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Veeva faces a critical Q1 earnings report after a 29% YTD share decline, with growth stabilization and AI progress in focus. VEEV's transition from Salesforce to Vault CRM and expansion of Crossix and the AI-driven Falcon platform are key strategic pivots. Guidance implies confidence: Q1 revenue $855–$858M, FY27 revenue $3.585–$3.60B, 44% margin, and strong free cash flow yield at 5.6%.

Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Global CDMO will unify sites on single quality platform for greater efficiency and scalability PLEASANTON, Calif., May 28, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Kindeva is adopting Veeva Quality Cloud to modernize its manufacturing operations, bringing together its global network of sites onto a single cloud platform.

Veeva Falcon works with Veeva clinical, regulatory, and safety applications to increase speed and lower costs PLEASANTON, Calif., May 27, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Falcon, an agentic platform and standard agents for life sciences' major drug development processes.

Agentic CRM with industry-specific AI for deeper customer engagement PLEASANTON, Calif., May 27, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Teva Pharmaceuticals has committed to Veeva Vault CRM globally.

Agentic CRM with deep industry-specific capabilities provides commercial foundation for the future PLEASANTON, Calif., May 27, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Merck KGaA, Darmstadt, Germany, has committed globally to Veeva Vault CRM.

VEEV's growing Vault CRM adoption and AI momentum, backed by major pharma wins, reinforce confidence in its long-term growth outlook.

Veeva Systems (VEEV) closed the most recent trading day at $158.27, moving 4.06% from the previous trading session.